Amit Agarwal is a highly experienced leader in the life sciences and healthcare sectors, currently serving as the Managing Director and West Coast lead of the Next Generation Cell & Gene Therapy Practice at Deloitte Consulting since November 2011. Prior to this role, Amit was a Principal at Deloitte, and a Partner at Scientia Advisors, focusing on growth strategies for life sciences companies. Amit's expertise extends to positions held at Leerink Swann & Company as Vice President and at A.T. Kearney as Principal, along with roles at marchFirst, Mitchell Madison Group, and Gemini Consulting. Amit's early career includes diplomatic service with the US Department of State and research at the California Institute of Technology. Educational credentials include an MBA from MIT Sloan School of Management, two certificates from the Foreign Service Institute in Arabic and Chinese language studies, and a Bachelor’s degree from Occidental College in History and Pre-med.